TITANIUM DIOXIDE
- Manufacturer
- Laboratoires Clarins
- Effective date
- 2019-03-22
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 3
- Source
- legacy-cache
- Hydrated at
- 2026-08-02 00:28:59
Label at a glance#
ProductClarins Everlasting Cushion Long-Wearing and Hydrating Foundation Broad Spectrum SPF 50 Tint 110 Refill with sponge
Active ingredientTITANIUM DIOXIDE
Label structure1 sections
Label contents#
Full prescribing information#
Products#
Every source-derived product name is available through these pages.
- Clarins Everlasting Cushion Long-Wearing and Hydrating Foundation Broad Spectrum SPF 50 Tint 110 Refill with sponge
- TITANIUM DIOXIDE
- WATER
- CYCLOMETHICONE 5
- PHENYL TRIMETHICONE
- CYCLOMETHICONE 6
- BUTYLENE GLYCOL
- DIPENTAERYTHRITYL HEXA C5-9 ACID ESTERS
- TRIETHYLHEXANOIN
- GLYCERIN
- ENSULIZOLE
- DIMETHICONE
- NIACINAMIDE
- TROMETHAMINE
- 1,2-HEXANEDIOL
- SORBITAN SESQUIOLEATE
- STEARIC ACID
- NYLON-12
- PEG-30 DIPOLYHYDROXYSTEARATE
- SODIUM CHLORIDE
- ZINC STEARATE
- ALUMINUM HYDROXIDE
- DISTEARYLDIMONIUM CHLORIDE
- .ALPHA.-TOCOPHEROL ACETATE
- DISTEARDIMONIUM HECTORITE
- TRIETHOXYCAPRYLYLSILANE
- ADENOSINE
- PALMITOYL PROLINE
- CHENOPODIUM QUINOA SEED
- MAGNESIUM PALMITOYL GLUTAMATE
- SODIUM PALMITOYL SARCOSINATE
- CERAMIDE NP
- PALMITIC ACID
- HYDROGENATED SOYBEAN LECITHIN
- LAPSANA COMMUNIS FLOWERING TOP
- DIPROPYLENE GLYCOL
- GLYCERETH-20
- GREEN TEA LEAF
- PEG-10 RAPESEED STEROL
- GLYCERYL MONOSTEARATE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 58668-9910 | 58668-9910-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| d055a6d2-ae24-5a99-e053-2995a90a805b | 7d6a7acb-331f-4e82-81ab-e51f5ee6cebd | 2021-11-09 | 7d6a7acb-331f-4e82-81ab-e51f5ee6cebd |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.


